Galapagos reported -76332000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
AstraZeneca AZN:LN 2.2B 673M
Biogen BIIB:US $ 940.9M 409.4M
Genmab GEN:DC 1.25B 733M
Gilead Sciences GILD:US $ 2029M 868M
GlaxoSmithKline GSK:LN 1.82B 600M
Hikma Pharmaceutical HIK:LN 256M 23M
Merck MRK:GR 1.35B 146M
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Novartis NOVN:VX 3.32B 176M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M
YTE INCY:US $ 260.29M 132.62M